← Fundnode · Learn

Funder comparison · 2026

Credibly vs Bluevine — who wins for what.

Both fund small businesses. They solve different problems. Here's the honest side-by-side, then five use-case verdicts so you don't have to guess.

By Fundnode Editorial7 min read

The specs

CrediblyBluevine
Product typeMulti-productLOC
Amount range$5K – $600K$10K – $250K
Cost (factor / APR)Factor 1.11+ (MCA); APR varies (term)APR 6.2% – 27% (LOC)
Speed to fundAs fast as 4 hours1 – 3 business days
Min time in business6 months12 months
Min monthly revenue$15,000$10,000
Min credit score550+625+
Products
  • MCA
  • Working capital LOC
  • Short-term term loan
  • Line of credit
  • Invoice factoring

Verdicts by use case

  • Capital amount for multi-clinic healthcare group capital needs — Winner: Credibly. Multi-clinic healthcare groups (dental groups, dermatology practices, physical therapy chains, urgent care chains, veterinary practice groups) typically need $200K – $600K capital for equipment standardization, clinic acquisition, or major expansion. Credibly MCA scales to $600K supporting multi-clinic capital needs; Bluevine LOC caps at $250K. For multi-clinic healthcare capital needs above $250K Credibly is structurally primary.
  • Healthcare receivables factoring as structural alternative — Winner: Tie. Healthcare practices have structurally favorable receivables factoring alternatives — Bankers Healthcare Group, HPS Healthcare Funding, Sterling National Bank Healthcare, MedCap Healthcare Capital — that advance against insurance receivables (Medicare, Medicaid, commercial insurance, dental insurance) at 1 – 4% factoring fee or 10 – 18% APR equivalent for healthcare-specific term capital. Tie because the realistic structural recommendation is to evaluate healthcare-specialty capital in parallel with both Credibly and Bluevine — healthcare-specialty options often beat both on cost and structural fit for healthcare-specific use cases.
  • Underwriting accommodation for multi-clinic group entity structures — Winner: Credibly. Multi-clinic healthcare groups often operate under multi-entity structures (one PC or LLC per clinic plus a parent management entity). Credibly's underwriting accommodates multi-entity healthcare groups by consolidating bank statements across operating entities under common ownership. Bluevine's LOC underwriting historically prefers single-entity bank statement consolidation. For multi-entity healthcare group structures Credibly is structurally more accommodating.
  • Speed for healthcare clinic operational emergencies — Winner: Credibly. Healthcare clinic operational emergencies (equipment failure, vendor COD, payroll bridge) benefit from Credibly's 4-hour funding window vs Bluevine's 1 – 3 business day funding. For healthcare clinic operational emergencies Credibly is structurally primary on speed.
  • Cost on A-paper multi-clinic groups fitting under $250K — Winner: Bluevine. A-paper multi-clinic healthcare groups (680+ FICO on principal physician, 36+ months TIB, $100K+/mo consolidated revenue) that fit capital needs under $250K benefit from Bluevine LOC APR 10 – 18% — materially cheaper than Credibly MCA factor 1.16 – 1.24 effective APR 30 – 50% typical for healthcare A-paper. For A-paper multi-clinic groups fitting Bluevine box Bluevine LOC is structurally primary on cost.

The honest takeaway

Credibly and Bluevine solve overlapping but distinct problems. The right choice depends on three things you already know about your business: how fast you need the money, how long you've been operating, and whether the capital need is one-time or recurring.

Frequently asked questions

How do healthcare practices balance insurance receivables factoring vs MCA / LOC capital?
Healthcare practices balance insurance receivables factoring vs MCA / LOC capital based on capital structure needs as of 2026-06-29. The realistic healthcare capital framework: (1) Insurance receivables factoring (Bankers Healthcare Group, HPS Healthcare Funding, MedCap Healthcare Capital) advances against billed insurance claims (Medicare, Medicaid, commercial insurance, dental insurance) before insurance payment. Pricing typically 1 – 4% factoring fee per invoice cycle; effective APR equivalent 12 – 30% depending on collection cycle (typically 30 – 90 days for healthcare insurance). Factoring fits ongoing working capital needs and scales automatically with insurance receivable volume. (2) Healthcare-specialty term capital (Bankers Healthcare Group, Provident Healthcare Partners, MidCap Financial, Marlin Business Bank) provides term loans, equipment financing, and acquisition financing for healthcare practices at 10 – 18% APR for established practices. Healthcare-specialty term capital fits lump-sum capital deployment needs (equipment, expansion, acquisition). (3) Mainstream MCA / LOC capital fits opportunistic capital deployment where healthcare-specialty alternatives don't fit timing or use case. Mainstream MCA pricing (Credibly factor 1.16 – 1.28 effective APR 30 – 55%) and LOC pricing (Bluevine APR 10 – 22%) are typically more expensive than healthcare-specialty alternatives. (4) Healthcare practice acquisition financing — practice acquisition financing specialists (Live Oak Bank, US Bank Practice Finance, Bank of America Practice Finance, Wells Fargo Practice Finance, PNC Bank Practice Finance) provide acquisition-specific capital at 8 – 14% APR for $250K – $5M+ practice acquisitions. The structural rule for healthcare practice capital: healthcare-specialty alternatives typically beat mainstream MCA / LOC on cost and structural fit for healthcare-specific use cases; mainstream MCA / LOC fits emergency or opportunistic capital deployment where healthcare-specialty alternatives don't fit. The realistic healthcare practice capital playbook: pursue insurance receivables factoring as primary ongoing working capital (for practices with strong insurance billing volume); pursue healthcare-specialty term capital for equipment, expansion, and acquisition (materially cheaper than mainstream alternatives); pursue practice acquisition financing for practice acquisition deals; pursue mainstream MCA / LOC for emergency capital or opportunistic deployment where healthcare alternatives don't fit; pursue SBA 7(a) for major capital deployment with timing tolerance.
What multi-clinic healthcare group capital structures make sense for a 3-clinic dental group doing $300K/mo consolidated?
A 3-clinic dental group doing $300K/mo consolidated revenue has multiple structural capital options as of 2026-06-29. The realistic dental group capital framework: (1) Insurance receivables factoring for ongoing working capital — Bankers Healthcare Group, HPS Healthcare Funding, MedCap Healthcare Capital advance against dental insurance billings at 1 – 4% factoring fee. Expected dental group factoring capacity at $300K/mo billings: $200K – $500K factoring line scaling with insurance billing volume. The structural fit is excellent for dental practices with consistent insurance billing patterns. (2) Healthcare-specialty term capital for equipment standardization across clinics — Bankers Healthcare Group, MidCap Financial, or specialty dental equipment financing (Henry Schein Financial Services, Patterson Financial Services, Benco Dental Financial Services) provide dental equipment financing at 8 – 14% APR for $50K – $250K per clinic equipment package. (3) Practice acquisition financing for clinic acquisition or expansion — Live Oak Bank, US Bank Practice Finance, Bank of America Practice Finance provide dental practice acquisition financing at 8 – 12% APR for $250K – $5M+ practice acquisitions. (4) Credibly MCA for opportunistic capital deployment — expected Credibly offer at $300K/mo consolidated revenue: $300K – $500K MCA at factor 1.18 – 1.24 for 9 – 12 month payback for opportunistic capital deployment (marketing campaign, new service launch, clinic remodel). Effective APR roughly 30 – 50%. (5) Bluevine LOC for revolving working capital — expected Bluevine offer at consolidated revenue: $250K line at APR 12 – 18% (capped at $250K) for revolving working capital management across clinics. (6) SBA 7(a) loan for major capital deployment — SBA 7(a) at prime + 2.75 – 4.75% APR (typically 11 – 13% as of 2026-06-29) supports up to $5M for major dental group capital deployment with 60 – 120 day approval cycle. (7) Dental-specific marketing capital programs — some dental marketing specialists offer revenue-share marketing capital programs that fund dental practice marketing campaigns in exchange for revenue share from generated new patient revenue. Specialty structure for dental practices with strong marketing ROI history. The structural rule for multi-clinic dental groups: layered capital strategy combining (a) insurance receivables factoring for ongoing working capital, (b) healthcare-specialty term capital for equipment standardization, (c) practice acquisition financing for clinic acquisition, (d) Bluevine LOC for revolving working capital under $250K cap, (e) Credibly MCA for opportunistic capital deployment, (f) SBA 7(a) for major planned deployment, produces structurally lowest total capital cost across the dental group lifecycle.
Which is right for a 4-clinic urgent care chain doing $400K/mo with 690 FICO on principal needing $400K for clinic 5 buildout?
Live Oak Bank or SBA 7(a) loan structurally primary for this file as of 2026-06-29 with Credibly MCA as bridge if timing requires. The realistic urgent care chain 5th-clinic buildout capital playbook: (1) Route to Live Oak Bank or other healthcare-specialty acquisition lender as structural primary — Live Oak Bank, US Bank Practice Finance, Bank of America Practice Finance, Wells Fargo Practice Finance, PNC Bank Practice Finance provide healthcare-specific acquisition and buildout financing at 8 – 12% APR for $250K – $5M+ deployments. Expected healthcare-specialty offer for 4-clinic urgent care chain with 690 FICO: $400K – $600K acquisition/buildout loan at 9 – 11% APR over 7 – 10 year term. Materially cheaper than mainstream MCA / LOC alternatives plus structural fit with healthcare practice lifecycle. (2) Evaluate SBA 7(a) loan in parallel — SBA 7(a) at prime + 2.75 – 4.75% APR (typically 11 – 13% as of 2026-06-29) supports up to $5M for major healthcare group capital deployment. SBA 7(a) timing (60 – 120 day approval cycle) typically fits planned clinic buildout (lease signed, construction timeline 90 – 180 days). For the file SBA 7(a) is structurally the cheapest capital option. (3) Evaluate Credibly MCA for emergency capital bridge — if healthcare-specialty lender or SBA timing doesn't fit clinic 5 buildout timeline, Credibly MCA provides immediate capital deployment. Expected Credibly offer at 690 FICO and $400K/mo consolidated revenue: $400K MCA at factor 1.16 – 1.22 for 9 – 12 month payback. Effective APR roughly 28 – 45%. Daily ACH amount approximately $1.5K – $2K. The pricing premium reflects MCA capital structure cost vs healthcare-specialty alternatives. (4) Bluevine LOC structurally inadequate for this file — capital need ($400K) exceeds Bluevine's $250K cap; Bluevine is not a viable structural primary in this 2-way for clinic 5 buildout at this capital amount. (5) Evaluate healthcare equipment financing for equipment portion of buildout — Henry Schein Financial Services, Patterson Financial Services, GE Healthcare Capital, Stryker Capital provide healthcare equipment financing at 8 – 14% APR for medical equipment portion of buildout. Equipment-specific financing typically beats general capital on cost for equipment portion. (6) Evaluate insurance receivables factoring for working capital bridge — Bankers Healthcare Group or HPS Healthcare Funding can advance against existing 4-clinic insurance receivables to provide working capital bridge during clinic 5 buildout period. (7) Construction-specific financing for construction portion of buildout — construction loan products from regional banks provide construction-specific capital with disbursement aligned to construction milestones at 8 – 14% APR. (8) Urgent care chain-specific considerations — urgent care chains face structural revenue ramp considerations for new clinic openings (typical 12 – 18 month ramp to profitability for new urgent care location); plan capital deployment to bridge ramp period; demonstrate ramp pattern from existing clinic openings to support underwriting. The structural rule for healthcare multi-clinic chain expansion capital: healthcare-specialty acquisition lenders (Live Oak Bank, US Bank Practice Finance, Bank of America Practice Finance) structurally primary for cost optimization; SBA 7(a) structurally cheapest if timing permits; mainstream MCA (Credibly) for emergency capital bridge where healthcare alternatives don't fit timing; healthcare equipment financing for equipment portion; insurance receivables factoring for working capital bridge; construction-specific financing for construction portion. The realistic recommendation: pursue Live Oak Bank or healthcare-specialty acquisition lender as structural primary; pursue SBA 7(a) in parallel for cost optimization; use Credibly MCA for emergency capital bridge only if specialty alternatives don't fit timing; layer healthcare equipment financing, insurance receivables factoring, and construction-specific financing for component portions of clinic 5 buildout.